Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial – PROFIT
Zhou, K., Renouf, M., Perrocheau, G., Magné, N., Latorzeff, I., Pommier, P., Créhange, G., Paumier, A., Bera, G., Martin, J., Catton, C., Bellanger, M., Supiot, S.
Published in Radiotherapy and oncology (01.08.2022)
Published in Radiotherapy and oncology (01.08.2022)
Get full text
Journal Article
Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients
Jacquet, E., Lardy-Cléaud, A., Pistilli, B., Franck, S., Cottu, P., Delaloge, S., Debled, M., Vanlemmens, L., Leheurteur, M., Guizard, A.V., Laborde, L., Uwer, L., Jacot, W., Berchery, D., Desmoulins, I., Ferrero, J.M., Perrocheau, G., Courtinard, C., Brain, E., Chabaud, S., Robain, M., Bachelot, T.
Published in European journal of cancer (1990) (01.05.2018)
Published in European journal of cancer (1990) (01.05.2018)
Get full text
Journal Article
Cost-Minimisation Analysis in First-Line Treatment of Metastatic Colorectal Cancer in France: XELOX versus FOLFOX-6
Perrocheau, G., Bennouna, J., Ducreux, M., Hebbar, M., Ychou, M., Lledo, G., Conroy, T., Dominguez, S., Faroux, R., Florentin, V., Douillard, J.Y.
Published in Oncology (01.01.2010)
Published in Oncology (01.01.2010)
Get full text
Journal Article
Cost Consequences of Adjuvant Capecitabine, Mayo Clinic and de Gramont Regimens for Stage III Colon Cancer in the French Setting
Douillard, J.Y., Tilleul, P., Ychou, M., Dufour, P., Perrocheau, G., Seitz, J.F., Maes, P., Lafuma, A., Husseini, F.
Published in Oncology (01.01.2007)
Published in Oncology (01.01.2007)
Get full text
Journal Article
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas
FETY, R, ROLLAND, F, MILANO, G, BARBERI-HEYOB, M, HARDOUIN, A, CAMPION, L, CONROY, T, MERLIN, J.-L, RIVIERE, A, PERROCHEAU, G, ETIENNE, M.-C
Published in Clinical cancer research (01.09.1998)
Get full text
Published in Clinical cancer research (01.09.1998)
Journal Article
Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer
Campone, M., Fumoleau, P., Delecroix, V., Deporte-Fety, R., Perrocheau, G., Vernillet, L., Borg-Olivier, O., Louboutin, J. P., Bissery, M.-C., Riva, A., Azli, N.
Published in Annals of oncology (01.07.2001)
Published in Annals of oncology (01.07.2001)
Get full text
Journal Article
Internet pharmaco-economic studies in metastatic colorectal cancer
Launois, R., Portafax, C., Le Lay, K., Mègnigbêto, A., Perrocheau, G.
Published in Critical reviews in oncology/hematology (01.04.2001)
Published in Critical reviews in oncology/hematology (01.04.2001)
Get full text
Journal Article
MO-0058 Cost-effectiveness of hypofractionated radiotherapy in intermediate-risk prostate cancer
Renouf, M., Zhou, K., Perrocheau, G., Magné, N., De Brisson de la Roche, G., Latorzeff, I., Pommier, P., Créhange, G., Paumier, A., Bera, G., Catton, C., Bellanger, M., Supiot, S.
Published in Radiotherapy and oncology (01.05.2022)
Published in Radiotherapy and oncology (01.05.2022)
Get full text
Journal Article
250P Association between progression free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: Evidence from the ESME real-world database
Courtinard, C.C., Gourgou, S., Jacot, W., M. Carton, Filleron, T., Couch, D., Asselain, B., Le Deley, M-C., Vacher, L., Antoine, A., Parent, D., R. Schiappa, Breton, M., Michiels, S., Brain, E.G.C., Guérin, O., Loeb, A., Perrocheau, G., Simon, G., Bellera, C.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
Abstract P6-14-06: Oral etoposide (VP-16) in heavily pre-treated metastatic breast cancer: A multicenter national observational study
Lerebours, F, Carton, M, Bacrie, J, Pierga, J-Y, Rouzier, R, Saghatchian, M, Dalenc, F, Mailliez, A, Levy, C, Firmin, N, Debled, M, Leheurteur, M, Desmoulins, I, Lefeuvre, C, Goncalves, A, Uwer, L, Ferrero, J-M, Eymard, J-C, Petit, T, Mouret-Reynier, M-A, Piot, I, Perrocheau, G, Caillot, C, Perol, D
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Exploratory analyses of surrogate endpoints in metastatic non-small cell lung cancer
Bouteiller, F., Cousin, S., Sofeu, C., Perrocheau, G., Gervais, R., Perol, M., Girard, N., Chamorey, E., Pasquier, D., Dubray Longeras, P., Kaderbhai, C., Schott, R., Filleron, T., Chouaid, C., Debieuvre, D., Valette, C. Audigier, Quantin, X., Bosquet, L., Martin, A., Bellera, C.
Published in Revue d'épidémiologie et de santé publique (01.06.2021)
Published in Revue d'épidémiologie et de santé publique (01.06.2021)
Get full text
Journal Article
Construction et évaluation d’un substitut de l’indice fonctionnel ECOG (PS), mesure de l’état de santé général du patient au diagnostic du cancer du sein métastatique
Courtinard, C., Asselain, B., Brain, E., Piot, I., Payen, O., Campion, L., Jaffré, A., Girerd-Chambaz, N., Pérol, D., Mathoulin-Pelissier, S., Diéras, V., Perrocheau, G., Robain, M.
Published in Revue d'épidémiologie et de santé publique (01.05.2018)
Published in Revue d'épidémiologie et de santé publique (01.05.2018)
Get full text
Journal Article
Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer
Spielmann, Marc, Llombart-Cussac, Antonio, Kalla, Salima, Espié, Marc, Namer, Moïse, Ferrero, Jean-Marc, Diéras, Véronique, Fumoleau, Pierre, Cuvier, Caroline, Perrocheau, Geneviève, Ponzio, Anne, Kayitalire, Louis, Pouillart, Pierre
Published in Oncology (01.01.2001)
Published in Oncology (01.01.2001)
Get full text
Journal Article
Cost-minimization analysis of a phase III study of capecitabine + oxaliplatin (XELOX) vs. infusional 5-FU/LV + oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer (MCRC) in the French setting
Perrocheau, G., Bennouna, J., Ducreux, M., Hebbar, M., Ychou, M., Lledo, G., Conroy, T., Adenis, A., Faroux, R., Douillard, J.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
CETUFTIRI, a new combination of UFT with leucovorin (LV), irinotecan, and cetuximab as first-line treatment for patients (pts) with unresectable metastatic colorectal cancer (mCRC): Preliminary results from a multicenter phase II trial
Bennouna, J., Faroux, R., François, E., Ligeza, C., El Hannani, C., Perrier, H., Jacob, J., Desseigne, F., Perrocheau, G., Douillard, J. Y.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Cost-effectiveness of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French setting
Dufour, P. R., Douillard, J., Ychou, M., Seitz, J., Perrocheau, G., Tilleul, P., Maes, P., Husseini, F.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Cost Consequences of Adjuvant Capecitabine, Mayo Clinic and de Gramont Regimens for Stage III Colon Cancer in the French Setting
Douillard, J Y, Tilleul, P, Ychou, M, Dufour, P, Perrocheau, G, Seitz, J F, Maes, P, Lafuma, A, Husseini, F
Published in Oncology (01.01.2008)
Get full text
Published in Oncology (01.01.2008)
Journal Article
EC3 COST-MINIMIZATION ANALYSIS OF CAPECITABINE + OXALIPLATIN (XELOX) VS. INFUSIONAL 5-FU/LV + OXALIPLATIN (FOLFOX-6) AS FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER (MCRC) IN THE FRENCH SETTING
Perrocheau, G, Ducreux, M, Hebbar, M, Ychou, M, Lledo, G, Conroy, T, Faroux, R, Douillard, JY, Pacull, A
Published in Value in health (2007)
Published in Value in health (2007)
Get full text
Journal Article